| 产品详情 |
| Edit |   |
|---|
| Product Name | Enhanced FasL Pack, Soluble, Recombinant, Human, aa103-281 |
|---|
| Description | Purity ~95% (SDS-PAGE). FasL, soluble induces apoptosis in a concentration range of <1ng/ml in the presence of 0.1-1ug/ml of TNF Ligands Enhancer. Binds to human and mouse Fas (CD95; APO-1). Induces apoptosis of human Jurkat T cells at a concentration of <0.2ng/ml. Intended Use: Binds to human and mouse Fas (CD95; APO-1). Induces apoptosis of human Jurkat T cells at a concentration of <0.2ng/ml. Specificity: Human and mouse Source: Recombinant protein corresponding to aa103-281 from human FasL, fused to a FLAG®-tag at N-terminal, expressed in HEK 293 cells. Kit Components: FasL, Soluble, Recombinant, Human: 1x10ug TNF Ligands Enhancer: 4x50ug Concentration: FasL: 0.1mg/ml after reconstitution TNF Ligands Enhancer: 1mg/ml after reconstitution Endotoxin Content: FasL: <0.05EU/ug (LAL test; Lonza). TNF Ligands Enhancer: <0.01EU/ug (LAL test; Lonza). |
|---|
| Size | 1 set |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Enhanced FasL Pack, Soluble, Recombinant, Human, aa103-281 (Apoptosis Antigen Ligand, APT1LG1, APTL, CD95 Ligand, CD95L, CD95-L, FAS Antigen Ligand, Fas Ligand, CD178, FASLG, Tumor Necrosis Factor Ligand Superfamily Member 6, TNFSF6) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 207165 |
|---|
| Price | |
|---|
| Order / More Info | Enhanced FasL Pack, Soluble, Recombinant, Human, aa103-281 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|